Browsing by Author Llovet i Bayer, Josep Maria

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 26  next >
Issue DateTitleAuthor(s)
1994Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitisLlovet i Bayer, Josep Maria; Bartolí, R.; Planas Vilà, Ramon; Cabré i Gelada, Eduard; Jiménez, M.; Urban, A.; Ojanguren Sabán, Isabel; Arnal, J.; Gassull, Miquel Àngel
12-Jan-2018Beta-catenin cleavage enhances transcriptional activationGoretsky, Tatiana; Bradford, Emily M.; Ye, Qing; Lamping, Olivia F.; Vanagunas, Tomas; Moyer, Mary Pat; Keller, Patrick C.; Sinh, Preetika; Llovet i Bayer, Josep Maria; Gao, Tianyan; She, Qing-Bai; Li, Linheng; Barrett, Terrence A.
9-Jan-2018Characterization of novel actionable molecular subgroups in Hepatocellular Carcinoma: Immune class and IGF2-driven tumorsMartínez Quetglas, Iris
2002Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.Llovet i Bayer, Josep Maria; Mas, X.; Aponte, John J.; Fuster Obregón, Josep; Navasa, Miquel; Christensen, E.; Rodés, J.; Bruix Tudó, Jordi
Jun-2015DNA methylation-based prognosis and epidrivers in hepatocellular carcinomaVillanueva, Augusto; Portela, Anna; Sayols, Sergi; Battiston, Carlo; Hoshida, Yujin; Méndez-González, Jesús; Imbeaud, Sandrine; Letouzé, Eric; Hernandez-Gea, Virginia; Cornella, Helena; Pinyol, Roser; Solé Arqués, Manuel; Fuster Obregón, Josep; Zucman-Rossi, Jessica; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria; HEPTROMIC Consortium
14-Apr-2016Hepatocellular carcinomaLlovet i Bayer, Josep Maria; Zucman-Rossi, Jessica; Pikarsky, Eli; Sangro, Bruno; Schwartz, Myron; Sherman, Morris; Gores, Gregory
2001Hepatocellular carcinoma: is surveillance cost effective?Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria
1-Sep-2017Identification of an immune-specific class of Hepatocellular Carcinoma, based on molecular featuresSia, Daniela; Jiao, Yang; Martinez Quetglas, Iris; Kuchuk, Olga; Villacorta Martin, Carlos; de Moura, Manuel Castro; Putra, Juan; Campreciós Figueras, Genís; Bassaganyas, Laia; Akers, Nicholas; Losic, Bojan; Waxman, Samuel; Thung, Swan N.; Mazzaferro, Vincenzo; Esteller, Manel; Friedman, Scott L.; Schwartz, Myron; Villanueva, Augusto; Llovet i Bayer, Josep Maria
1-Dec-2016IGF2 is up-regulated by epigenetic mechanisms in Hepatocellular Carcinoma and is an actionable oncogene product in experimental modelsMartinez Quetglas, Iris; Pinyol, Roser; Dauch, Daniel; Torrecilla, Sara; Tovar, Victoria; Moeini, Agrin; Alsinet, Clara; Portela, Anna; Rodriguez Carunchio, Leonardo; Sole, Manel; Lujambio, Amaia; Villanueva, Augusto; Thung, Swan N.; Esteller, Manel; Zender, Lars; Llovet i Bayer, Josep Maria
Mar-2016Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient PrognosisSia, Daniela; Villanueva, Augusto; Friedman, Scott L.; Llovet i Bayer, Josep Maria
1996Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trialForns, Xavier; Ampurdanés, Sergi; Titó Espinagosa, Llúcia; Planas Vilà, Ramon; Viver i Pi-Suñer, Josep M.; Acero i Fernández, Doroteo; Torres Salinas, Miguel; Mas, P.; Morillas Cunill, Rosa María; Forné Bardera, Montserrat; Espinós, J.; Llovet i Bayer, Josep Maria; Costa i Camps, Josep; Olmedo Casas, Eva; López Labrador, Francesc Xavier; Jiménez de Anta Losada, María Teresa; Rodés, J.; Sánchez-Tapias, J.M.
23-Jan-2017Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entityMoeini, Agrin; Sia, Daniela; Zhang, Zhongyang; Campreciós Figueras, Genís; Stueck, Ashley; Dong, Hui; Montal, Robert; Torrens, Laura; Martinez Quetglas, Iris; Fiel, Maria Isabel; Hao, Ke; Villanueva, Augusto; Thung, Swan N.; Schwartz, Myron; Llovet i Bayer, Josep Maria
2016Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibitionNakagawa, Shigeki; Wei, Lan; Song, Won Min; Higashi, Takaaki; Ghoshal, Sarani; Kim, Rosa S.; Bian, C. Billie; Yamada, Suguru; Sun, Xiaochen; Venkatesh, Anu; Goossens, Nicolas; Bain, Gretchen; Lauwers, Gregory Y.; Koh, A. P.; El-Abtah, Mohamed; Ahmad, Noor B.; Hoshida, Hiroki; Erstad, Derek J.; Gunasekaran, Ganesh; Lee, Youngmin; Yu, Ming-Lung; Chuang, Wan-Long; Dai, Chia-Yen; Kobayashi, Masahiro; Kumada, Hiromitsu; Beppu, Toru; Baba, Hideo; Mahajan, Milind; Nair, Venugopalan D.; Lanuti, Michael; Villanueva, Augusto; Sangiovanni, Angelo; Iavarone, Massimo; Colombo, Massimo; Llovet i Bayer, Josep Maria; Subramanian, Aravind; Tager, Andrew M.; Friedman, Scott L.; Baumert, Thomas F.; Schwartz, Myron E.; Chung, Raymond T.; Tanabe, Kenneth K.; Zhang, Bin; Fuchs, Bryan C.; Hoshida, Yujin; Precision Liver Cancer Prevention Consortium
30-Jul-2018Molecular therapies and precision medicine for hepatocellular carcinomaLlovet i Bayer, Josep Maria; Montal, Robert; Sia, Daniela; Finn, Richard S.
2-Jul-2014Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSaha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Akbay, Esra A.; Sia, Daniela; Cornella, Helena; Miltiadous, Oriana; Walesky, Chad; Deshpande, Vikram; Zhu, Andrew X.; Hezel, Aram F.; Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia; Ferrone, Cristina R.; Apte, Udayan; Llovet i Bayer, Josep Maria; Wong, Kwok-Kin; Ramaswamy, Sridhar; Bardeesy, Nabeel
25-Jan-2017Objective response by mRECIST as a predictor and potential surrogate end point of overall survival in advanced HCCLencioni, Riccardo; Montal, Robert; Torre, Ferran; Park, Joong-Won; Decaens, Thomas; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa Y.; Rios, José; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Llovet i Bayer, Josep Maria
14-Nov-2016Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaBollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina; Venkatesh, Anu; Bian, C.Billie; Roberto, Mark P.; Tovar, Victoria; Sia, Daniela; Molina Sánchez, Pedro; Nguyen, Christie B.; Nakagawa, Shigeki; Llovet i Bayer, Josep Maria; Hoshida, Yujin; Lujambio, Amaia
15-Nov-2017Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteriaLlovet i Bayer, Josep Maria; Pavel, Mihai; Rimola, Jordi; Diaz, Maria Alba; Colmenero, Jordi; Saavedra, David; Fondevila Campo, Constantino; Ayuso Colella, Carmen; Fuster Obregón, Josep; Ginès i Gibert, Pere; Bruix Tudó, Jordi; García-Valdecasas Salgado, Juan Carlos
Dec-2015Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.Miltiadous, Oriana; Sia, Daniela; Hoshida, Yujin; Fiel, Maria Isabel; Harrington, Andrew N.; Thung, Swan N.; Seng Tan, Poh; Dong, Hui; Revill, Kate; Chang, Charissa Y.; Roayaie, Sasan; Byrne, Thomas J.; Mazzaferro, Vincenzo; Rakela, Jorge; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria
20-Mar-2014Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'Llovet i Bayer, Josep Maria; Johnson, Philip J.